PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Vaxtex Cotfab Limited

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Vaxtex Cotfab Limited's yearly results (2023–2026), compared with Consumer Cyclical companies in India. Tap ? on any ratio for what it means.

What stands out

  • Shareholder Slice Ratio: Share count rose 38% in 3 years, so each share's slice of the company became smaller. Bigger rise in share count than 95% of Consumer Cyclical companies in India.
  • Debt Due Cover Ratio: Operating cash was negative last year, while some debt falls due within a year. Lower than 95% of Consumer Cyclical companies in India.
  • Cash Locked Ratio: For every ₹100 of sales, ₹50 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹17 from others' credit three years earlier. More money tied up than 88% of Consumer Cyclical companies in India.

Where ₹100 of sales goes

₹83Operating costs₹0.7Interest₹49Net profit

Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

—

Loss-making or profit too small

Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.

Self-Funding Ratio

—

Data incomplete

Cash Locked Ratio

₹50

For every ₹100 of sales, ₹50 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹17 from others' credit three years earlier.

More money tied up than 88% of Consumer Cyclical companies in India.

Growth quality

Steadiness Ratio

1/3 · 2/3

Sales grew in 1 of the last 3 years; profit grew in 2 of 3.

Less steady than 77% of Consumer Cyclical companies in India.

Growth Efficiency Ratio

—

Sales fell 83%

Sales fell 83% in 3 years, so extra profit per extra sales cannot be measured.

Asset Productivity Ratio

-83% / -47%

In 3 years sales changed by -83% while total assets changed by -47%. Assets grew faster than sales.

Balance-sheet strength

Debt Due Cover Ratio

-0.6×

Operating cash was negative last year, while some debt falls due within a year.

Lower than 95% of Consumer Cyclical companies in India.

Cash Cushion Ratio

−15%

Debt, after subtracting cash, equals 15% of its market value (net debt).

Lower than 60% of Consumer Cyclical companies in India.

Tangible Assets Ratio

—

Data incomplete

Tangible Net Worth Ratio

—

Data incomplete

Shareholders

Shareholder Slice Ratio

+38%

Share count rose 38% in 3 years, so each share's slice of the company became smaller.

Bigger rise in share count than 95% of Consumer Cyclical companies in India.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (14)

Vaxtex Cotfab Limited owes ₹0.39 for every ₹1 it owns. Net profit rose 525% in the year to Mar 2026, and grew 70% a year on average over 3 years.

Compared with Consumer Cyclical companies in India · latest annual results Mar 2026.

P/E ratio

5.1

Investors pay ₹5.1 for every ₹1 of Vaxtex Cotfab Limited's yearly profit, lower than 96% of Consumer Cyclical companies in India.

P/B ratio

1.21

The share price is 1.21 times Vaxtex Cotfab Limited's book value per share, lower than 75% of Consumer Cyclical companies in India.

Market cap

₹27 Cr

The total market value of all of Vaxtex Cotfab Limited's shares at today's price (share price × number of shares), smaller than 97% of Consumer Cyclical companies in India. PosiCap size class: Nano Cap.

Net worth (book value)

₹22 Cr

What Vaxtex Cotfab Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).

Book value per share

₹1.22

Net worth divided by the number of shares. The share price of ₹1.48 is 1.2 times this, which is the P/B above.

Return on equity (ROE)

24.0%

Vaxtex Cotfab Limited earned 24.0% on its shareholders' money over the last year, higher than 87% of Consumer Cyclical companies in India.

Owes vs Owns

0.39×

Vaxtex Cotfab Limited owes ₹0.39 for every ₹1 it owns (low), lower than 58% of Consumer Cyclical companies in India.

Dividend yield

None

Vaxtex Cotfab Limited does not currently pay a dividend.

Revenue growth

+113%

Revenue rose 113% in the year to Mar 2026, and shrank 45% a year on average over 3 years.

Profit growth

+525%

Net profit rose 525% in the year to Mar 2026, and grew 70% a year on average over 3 years.

Profit margin

49.5%

Vaxtex Cotfab Limited keeps ₹49 of every ₹100 of revenue as net profit.

Cash quality

-0.4×

Cash from Vaxtex Cotfab Limited's business was -0.4× its reported profit in the year to Mar 2026 — the business used cash even though it reported a profit.

Interest cover

25.7×

Vaxtex Cotfab Limited's operating profit covered its interest costs 25.7 times in the year to Mar 2026.

Cash vs debt

Net debt

Vaxtex Cotfab Limited had ₹4 Cr more debt than cash (net debt) at Mar 2026.

Questions

What is Vaxtex Cotfab Limited's P/E ratio?

Investors pay ₹5.1 for every ₹1 of Vaxtex Cotfab Limited's yearly profit, lower than 96% of Consumer Cyclical companies in India.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Vaxtex Cotfab Limited: ₹27 Cr ÷ ₹22 Cr (31 Mar 2026) = 1.2.

What is Vaxtex Cotfab Limited's return on equity?

Vaxtex Cotfab Limited earned 24.0% on its shareholders' money over the last year, higher than 87% of Consumer Cyclical companies in India.

How much does Vaxtex Cotfab Limited owe compared with what it owns?

Vaxtex Cotfab Limited owes ₹0.39 for every ₹1 it owns (low), lower than 58% of Consumer Cyclical companies in India.

Does Vaxtex Cotfab Limited pay a dividend?

No. Vaxtex Cotfab Limited does not currently pay a dividend.

Is Vaxtex Cotfab Limited's revenue growing?

Revenue rose 113% in the year to Mar 2026, and shrank 45% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.